UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)		May 21, 2013
BIOLOGIX HAIR INC.
(Exact name of registrant as specified in its charter)
Nevada	000-54882			27-4588540
(State or other jurisdiction of incorporation)	(Commission File Number)			(IRS Employer Identification No.)
82 Avenue Road, Toronto, Ontario, Canada				M5R 2H2
(Address of principal executive offices)				(Zip Code)
Registrant’s telephone number, including area code			(647) 344-5900
n/a
(Former name or former address, if changed since last report.)

Date of Report (Date of earliest event reported) June 1, 2013

BIOLOGIX HAIR INC.
(Exact name of registrant as specified in its charter)

Nevada		000-54882		27-4588540
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

82 Avenue Road, Toronto, Ontario, Canada		M5R 2H2
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code (647) 344-5900

n/a
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 1.01 Item 3.02 Entry into Material Definitive Agreement Unregistered Sales of Equity Securities

~~Item~~As 3previously filed on January 14, 2013, Biologix Hair Science Ltd.02 ~~Unregistered~~(“BHSL”), ~~Sales~~our wholly-owned subsidiary, entered into an intellectual property purchase and sale agreement and related convertible grid promissory note dated April 10, 2012 with Hair Research and Science Est. (“HRSE”), a company incorporated under the laws of ~~Equity~~the ~~Securities~~Principality of Liechtenstein. The agreement and convertible note were subsequently amended by agreements dated August 1, 2012 and November 30, 2012 (collectively, the “Purchase Agreement”).

~~Effective~~Pursuant ~~May~~to ~~21,~~the ~~2013~~Purchase Agreement, ~~our~~BHSL ~~company~~acquired ~~granted~~100% ~~an aggregate~~ of ~~3,525,000~~all ~~stock options to certain employees~~right, ~~officers,~~title ~~directors~~ and ~~consultants~~interest ofthroughout ~~our~~the ~~company~~world ~~pursuant~~in and to ~~our~~the ~~2013~~Biologix ~~Stock~~Revive ~~Plan. The~~Hair ~~stock~~FormulaTM and ~~options~~the ~~are~~Biologix ~~exercisable~~Hair ~~for~~Therapy ~~five~~SystemTM, ~~years~~including ~~from~~all ~~the~~related ~~date~~formulae, ofproducts, ~~grant~~processes, atand antechnical ~~exercise price of $2~~know-how.~~50 per share.~~

~~Also~~Effective ~~effective~~June ~~May 21~~1, 2013, ~~our~~BHSL ~~company~~and HRSE entered into ~~stock~~an ~~option~~amending ~~agreements~~agreement ~~with~~to ~~certain~~amend ~~employees~~the Purchase Agreement. Pursuant to the amending agreement, ~~officers~~our company will issue 300,000 ~~directors~~shares in our capital stock to HRSE and ~~consultants~~BHSL will issue to HRSE a promissory note in ~~connection~~the aggregate principal amount of $10,099,385 owing at May 31, 2013 with ~~granting~~an interest rate, on any principal amount outstanding, of 7%, increasing to a rate of 12% on December 31, 2013 and increasing to a rate of 24% on March 31, 2014. In consideration for the ~~stock~~above, ~~options~~HRSE will return the convertible note to BHSL for cancellation. All other material terms of the Purchase Agreement have not changed.

AnOn ~~aggregate~~June of1, ~~550~~2013,~~000~~ ~~stock~~an ~~options~~aggregate ~~were~~of ~~issued to four (4) US persons~~300,000 ~~relying~~shares onin ~~Rule~~the ~~506~~capital ~~under~~stock ~~Regulation D and/or Section 4(2)~~ of the ~~Securities Act of 1933~~Company, asat ~~amended,~~a ~~and~~deemed anprice ~~aggregate~~ of $2.50 per share,~~975,000~~ ~~stock~~were ~~options~~issued to ~~sixteen~~one (161) non-US person (as that term is defined in Regulation S of the Securities Act of 1933) in an offshore transaction relying on Regulation S of the Securities Act of 1933, as amended.

Item 9.01	~~Financial Statements and Exhibits~~	Financial Statements and Exhibits
10.1	~~Form of Stock Option Agreement~~	Intellectual Property Purchase and Sale Agreement and Convertible Grid Promissory Note dated April 11, 2012 between Biologix Hair Science Ltd. and Hair Research and Science Est. (incorporated by reference to our Current Report on Form 8-K filed on January 14, 2013).
10.2		Amending Agreement dated August 1, 2012 between Biologix Hair Science Ltd. and Hair Research and Science Est. (incorporated by reference to our Current Report on Form 8-K filed on January 14, 2013)
10.3		Amending Agreement dated November 30, 2012 between Biologix Hair Science Ltd. and Hair Research and Science Est. (incorporated by reference to our Current Report on Form 8-K filed on January 14, 2013).
10.4		Amending Agreement dated June 1, 2013 between Biologix Hair Science Ltd. and Hair Research and Science Est.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BIOLOGIX HAIR INC.
/s/ Ronald Holland
Ronald Holland
Director
Date:	~~June~~July 252, 2013

Filing Compare · BIOLOGIX HAIR INC.